Angiotensin-converting enzyme gene polymorphism in Nepal. 1998

S Umemura, and T Kawasaki, and T Ishigami, and T Fujita, and K Hibi, and M Kawasaki, and K Itoh, and Y Yoshimizu, and T Ogaki, and G P Acharya, and M Ishii
Second Department of Internal Medicine, Yokohama City University, Yokohama, Japan.

It has recently been found that there were very few hypertensives in the inhabitants of one Nepalese village, even though their salt consumption, per capita, was as high as citizens in many western countries. To evaluate the genetic factors involved in this phenomenon, we studied whether they had a special genotype distribution of angiotensin-converting enzyme (ACE) gene I/D polymorphism, which was recently reported to be involved in salt sensitivity. One hundred and thirty-eight subjects were evaluated in Nepal. Only nine subjects (6.5%) in this population were hypertensives (over 140/90 mm Hg) while consuming 11 g salt/day, which confirmed the previous results. The distribution of genotypes and alleles of ACE gene I/D polymorphism was similar to that in the Japanese and Chinese, who had five-times more hypertensives while consuming almost as much salt as Nepalese, but significantly different from those in Caucasians. The present study reports, for the first time, the genotype distribution of ACE gene I/D polymorphism in Nepalese subjects. Furthermore, the results suggest ACE gene polymorphism may not be involved in the 'salt-resistance' in this population.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007703 Peptidyl-Dipeptidase A A peptidyl-dipeptidase that catalyzes the release of a C-terminal dipeptide, oligopeptide-|-Xaa-Yaa, when Xaa is not Pro, and Yaa is neither Asp nor Glu. Thus, conversion of ANGIOTENSIN I to ANGIOTENSIN II, with increase in vasoconstrictor activity, but no action on angiotensin II. It is also able to inactivate BRADYKININ, a potent vasodilator; and has a glycosidase activity which releases GPI-anchored proteins from the membrane by cleaving the mannose linkage in the GPI moiety. (From https://www.uniprot.org April 15, 2020). ACE1 Angiotensin-Converting Enzyme 1,ACE1 Protein,Angiotensin Converting Enzyme,Angiotensin Converting Enzyme 1,Antigens, CD143,CD143 Antigens,Dipeptidyl Carboxypeptidase I,Kininase II,Peptidase P,Angiotensin I-Converting Enzyme,Carboxycathepsin,Dipeptidyl Peptidase A,Kininase A,ACE1 Angiotensin Converting Enzyme 1,Angiotensin I Converting Enzyme,Carboxypeptidase I, Dipeptidyl,Peptidyl Dipeptidase A
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009390 Nepal Country located in southern Asia, between China and India. The capital is Kathmandu. Federal Democratic Republic of Nepal
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

S Umemura, and T Kawasaki, and T Ishigami, and T Fujita, and K Hibi, and M Kawasaki, and K Itoh, and Y Yoshimizu, and T Ogaki, and G P Acharya, and M Ishii
July 2006, Nihon rinsho. Japanese journal of clinical medicine,
S Umemura, and T Kawasaki, and T Ishigami, and T Fujita, and K Hibi, and M Kawasaki, and K Itoh, and Y Yoshimizu, and T Ogaki, and G P Acharya, and M Ishii
June 1995, Journal of hypertension,
S Umemura, and T Kawasaki, and T Ishigami, and T Fujita, and K Hibi, and M Kawasaki, and K Itoh, and Y Yoshimizu, and T Ogaki, and G P Acharya, and M Ishii
April 2004, Clinical rheumatology,
S Umemura, and T Kawasaki, and T Ishigami, and T Fujita, and K Hibi, and M Kawasaki, and K Itoh, and Y Yoshimizu, and T Ogaki, and G P Acharya, and M Ishii
January 1998, The American journal of cardiology,
S Umemura, and T Kawasaki, and T Ishigami, and T Fujita, and K Hibi, and M Kawasaki, and K Itoh, and Y Yoshimizu, and T Ogaki, and G P Acharya, and M Ishii
June 2000, Cell biochemistry and function,
S Umemura, and T Kawasaki, and T Ishigami, and T Fujita, and K Hibi, and M Kawasaki, and K Itoh, and Y Yoshimizu, and T Ogaki, and G P Acharya, and M Ishii
February 1994, Lancet (London, England),
S Umemura, and T Kawasaki, and T Ishigami, and T Fujita, and K Hibi, and M Kawasaki, and K Itoh, and Y Yoshimizu, and T Ogaki, and G P Acharya, and M Ishii
February 1996, American journal of respiratory and critical care medicine,
S Umemura, and T Kawasaki, and T Ishigami, and T Fujita, and K Hibi, and M Kawasaki, and K Itoh, and Y Yoshimizu, and T Ogaki, and G P Acharya, and M Ishii
January 2003, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis,
S Umemura, and T Kawasaki, and T Ishigami, and T Fujita, and K Hibi, and M Kawasaki, and K Itoh, and Y Yoshimizu, and T Ogaki, and G P Acharya, and M Ishii
November 1997, Clinical science (London, England : 1979),
S Umemura, and T Kawasaki, and T Ishigami, and T Fujita, and K Hibi, and M Kawasaki, and K Itoh, and Y Yoshimizu, and T Ogaki, and G P Acharya, and M Ishii
May 1998, Biochemical Society transactions,
Copied contents to your clipboard!